Table I.

Details of the investigated and reference genes.

Gene	Primer sequence
AIF	Forward: 5′-CTGAAAGACGGCAGGAAGGTAG-3′
	Reverse: 5′-CTCCAGCCAATCTTCCACTCAC-3′
AKT	Forward: 5′-GGCTATTGTGAAGGAGGGTTG-3′
	Reverse 5′-TCCTTGTAGCCAATGAAGGTG-3′
BAX	Forward: 5′-AGATGTGGTCTATAATGCGTTTTCC-3′
	Reverse: 5′-CAGAAGGCACTAATCAAGTCAAGGT-3′
BCL2	Forward: 5′-AACATCGCCCTGTGGATGAC-3′,
	Reverse: 5′-AGAGTCTTCAGAGACAGCCAGGAG-3
BECN1	Forward: 5′-AGCTGCCGTTATACTGTTCTG-3′
	Reverse: 5′-ACTGCCTCCTGTGTCTTCAATCTT-3′
CASP3	Forward: 5-TGGTTCATCCAGTCGCTTTG-3′
	Reverse: 5′-CATTCTGTTGCCACCTTTCG-3′
CD44	Forward: 5′-ACCCCAACTCCATCTGTGC-3′
	Reverse: 5′-TTCTGGACATAGCGGGTG-3′
GAPDH	Forward: 5′-ACAACTTTGGTATCGTGGAAGG-3′
	Reverse: 5′-GCCATCACGCCACAGTTTC-3′
MAP1LC3B	Forward: 5′-CGGTGATAATAGAACGATACAAGG-3′
	Reverse: 5′-CTGAGATTGGTGTGGAGACG-3′
MMP2	Forward: 5′-GATACCCCTTTGACGGTAAGGA-3′
	Reverse: 5′-CCTTCTCCCAAGGTCCATAGC-3′
MMP9	Forward: 5′-CCCTGGAGACCTGAGAACCA-3′
	Reverse: 5′-CCCGAGTGTAACCATAGCGG-3′
MTOR	Forward: 5′-TCACATTACCCCCTTCACCA-3′
	Reverse: 5′-TCAGCGAGTTCTTGCTATTCC-3′
PI3K	Forward: 5′-AGTAGGCAACCGTGAAGAAAAG-3′
	Reverse: 5′-GAGGTGAATTGAGGTCCCTAAGA-3′
PYK2	Forward: 5′-GAGACCTACCGCTGTGAAC-3′
	Reverse: 5′-CTGCTAGGGATGAGGTTTTG-3′
RHOA	Forward: 5′-CCAAATGTGCCCATCATCCTAGTTG-3′
	Reverse: 5′-TCCGTCTTTGGTCTTTGCTGAACAC-3′
RIP3	Forward: 5′-AATTCGTGCTGCGCCTAGAAG-3′
	Reverse: 5′-TCGTGCAGGTAAAACATCCCA-3′
ROCK1	Forward: 5′-GGTGCTGGTAAGAGGGCATT-3′
	Reverse: 5′-AGCATCCAATCCATCCAGCAA-3′
SNAI1	Forward: 5′-TTCAACTGCAAATACTGCAACAAG-3′
	Reverse: 5′-CGTGTGGCTTCGGATGTG-3′
SNAI2	Forward: 5′-TGTGACAAGGAATATGTGAGCC-3′
	Reverse: 5′-TGAGCCCTCAGATTTGACCTG-3′
SQSTM1/P62	Forward: 5′-GGGGACTTGGTTGCCTTTT-3′
	Reverse: 5′-CAGCCATCGCAGATCACATT-3′
TWIST	Forward: 5′-GTCCGCAGTCTTACGAGGAG-3′
	reverse: 5′-GCTTGAGGGTCTGAATCTTGCT-3′
VIM	Forward: 5′- AGTCCACTGAGTACCGGAGAC-3′
	Reverse: 5′-CATTTCACGCATCTGGCGTTC-3′